Genetic features of ancient West Siberian people of the Middle Ages, revealed by mitochondrial DNA haplogroup analysis

Journal of Human Genetics

Volumn 56, Issue 8, 2011, Pages 602-608

  Sato, Takehiro ^a   Razhev, Dmitry ^b   Amano, Tetsuya ^a   Masuda, Ryuichi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b Institute of Problems of Development of the North of the Siberian Branch of the RAS   (Russian Federation)

Author keywords

ancient DNA; Middle Ages; mitochondrial DNA haplogroup; Ural Mountains; West Siberia

Indexed keywords

MITOCHONDRIAL DNA;

ARCHEOLOGY; ARTICLE; DNA SEQUENCE; GEOGRAPHY; HAPLOTYPE; HUMAN; MIDDLE AGES; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; POPULATION DIFFERENTIATION; POPULATION GENETIC STRUCTURE; POPULATION GENETICS; RUSSIAN FEDERATION;

ARCHAEOLOGY; DNA, MITOCHONDRIAL; GENETIC VARIATION; GENETICS, POPULATION; GEOGRAPHY; HAPLOTYPES; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; POLYMERASE CHAIN REACTION; PRINCIPAL COMPONENT ANALYSIS; SEQUENCE ANALYSIS, DNA; SIBERIA;

EID: 80052121079     PISSN: 14345161     EISSN: 1435232X     Source Type: Journal    
DOI: 10.1038/jhg.2011.68     Document Type: Article

References (40)

1. Jemal, A., Siegel, R., Xu, J. & Ward, E. Cancer statistics, 2010. CA Cancer J. Clin. 60, 277-300 (2010).
2. Hardisson, D. Molecular pathogenesis of head and neck squamous cell carcinoma. Eur. Arch. Otorhinolaryngol. 260, 502-508 (2003). (Pubitemid 37363578)
3. Leemans, C. R., Braakhuis, B. J. & Brakenhoff, R. H. The molecular biology of head and neck cancer. Nat. Rev. Cancer 11, 9-22 (2011).
4. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004).
5. Filipowicz, W., Bhattacharyya, S. N. & Sonenberg, N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat. Rev. Genet. 9, 102-114 (2008).
6. Calin, G. A. & Croce, C. M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 6, 857-866 (2006). (Pubitemid 44629897)
7. Esquela-Kerscher, A. & Slack, F. J. Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer 6, 259-269 (2006).
8. Chiyomaru, T., Enokida, H., Tatarano, S., Kawahara, K., Uchida, Y., Nishiyama, K. et al. miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br. J. Cancer 102, 883-891 (2010).
9. Ichimi, T., Enokida, H., Okuno, Y., Kunimoto, R., Chiyomaru, T., Kawamoto, K. et al. Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int. J. Cancer 125, 345-352 (2009).
10. Kano, M., Seki, N., Kikkawa, N., Fujimura, L., Hoshino, I., Akutsu, Y. et al. miR-145, miR-133a and miR-133b: tumor suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int. J. Cancer 127, 2804-2814 (2010).
11. Kikkawa, N., Hanazawa, T., Fujimura, L., Nohata, N., Suzuki, H., Chazono, H. et al. miR-489 is a tumour-suppressive miRNA target PTPN11 in hypopharyngeal squamous cell carcinoma (HSCC). Br. J. Cancer 103, 877-884 (2010).
12. Yoshino, H., Chiyomaru, T., Enokida, H., Kawakami, K., Tatarano, S., Nishiyama, K. et al. The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. Br. J. Cancer 104, 808-818 (2011).
13. Mutallip, M., Nohata, N., Hanazawa, T., Kikkawa, N., Horiguchi, S., Fujimura, L. et al. Glutathione S-transferase P1 (GSTP1) suppresses cell apoptosis and its regulation by miR-133alpha in head and neck squamous cell carcinoma (HNSCC). Int. J. Mol. Med. 27, 345-352 (2011).
14. Nohata, N., Hanazawa, T., Kikkawa, N., Mutallip, M., Fujimura, L., Yoshino, H. et al. Caveolin-1 mediates tumor cell migration and invasion and its regulation by miR-133a in head and neck squamous cell carcinoma. Int. J. Oncol. 38, 209-217 (2011).
15. Nohata, N., Sone, Y., Hanazawa, T., Fuse, M., Kikkawa, N., Yoshino, H. et al. miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma. Oncotarget 2, 29-44 (2011).
16. Avissar, M., Christensen, B. C., Kelsey, K. T. & Marsit, C. J. MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clin. Cancer Res. 15, 2850-2855 (2009).
17. Hui, A. B., Lenarduzzi, M., Krushel, T., Waldron, L., Pintilie, M., Shi, W. et al. Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin. Cancer Res. 16, 1129-1139 (2010).
18. Tsukamoto, Y., Nakada, C., Noguchi, T., Tanigawa, M., Nguyen, L. T., Uchida, T. et al. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res. 70, 2339-2349 (2010).
19. Liu, A. M., Poon, R. T. & Luk, J. M. MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties. Biochem. Biophys. Res. Commun. 394, 623-627 (2010).
20. Ding, L., Xu, Y., Zhang, W., Deng, Y., Si, M., Du, Y. et al. MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. Cell Res. 20, 784-793 (2010).
21. Li, X., Lin, R. & Li, J. Epigenetic silencing of microRNA-375 regulates PDK1 expression in esophageal cancer. Dig. Dis. Sci. (e-pub ahead of print 30 April 2011; PMID: 21533613).
22. Sugimoto, T., Seki, N., Shimizu, S., Kikkawa, N., Tsukada, J., Shimada, H. et al. The galanin signaling cascade is a candidate pathway regulating oncogenesis in human squamous cell carcinoma. Genes Chromosomes Cancer 48, 132-142 (2009).
23. Hu, G., Wei, Y. & Kang, Y. The multifaceted role of MTDH/AEG-1 in cancer progression. Clin. Cancer Res. 15, 5615-5620 (2009).
24. Sarkar, D., Emdad, L., Lee, S. G., Yoo, B. K., Su, Z. Z. & Fisher, P. B. Astrocyte elevated gene-1: far more than just a gene regulated in astrocytes. Cancer Res. 69, 8529-8535 (2009).
25. Almeida, M. I., Reis, R. M. & Calin, G. A. MicroRNA history: discovery, recent applications, and next frontiers. Mutat. Res. (e-pub ahead of print 30 March 2011; PMID: 21458467).
26. Tran, N., O'Brien, C. J., Clark, J. & Rose, B. Potential role of micro-RNAs in head and neck tumorigenesis. Head Neck 32, 1099-1111 (2010).
27. Glazer, C. A., Chang, S. S., Ha, P. K. & Califano, J. A. Applying the molecular biology and epigenetics of head and neck cancer in everyday clinical practice. Oral Oncol. 45, 440-446 (2009).
28. Chiyomaru, T., Enokida, H., Kawakami, K., Tatarano, S., Uchida, Y., Kawahara, K. et al. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer. Urol. Oncol. (e-pub ahead of print 14 September 2010; PMID: 20843712).
29. Chiyomaru, T., Tatarano, S., Kawakami, K., Enokida, H., Yoshino, H., Nohata, N. et al. SWAP70, actin-binding protein, function as an oncogene targeting tumor-suppressive miR-145 in prostate cancer. Prostate (e-pub ahead of print 25 February 2011; PMID: 21360565).
30. Fuse, M., Nohata, N., Kojima, S., Sakamoto, S., Chiyomaru, T., Kawakami, K. et al. Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1. Int. J. Oncol. 38, 1093-1101 (2011).
31. Zhang, B., Liu, X. X., He, J. R., Zhou, C. X., Guo, M., He, M. et al. Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer. Carcinogenesis 32, 2-9 (2011).
32. Su, Z. Z., Kang, D. C., Chen, Y., Pekarskaya, O., Chao, W., Volsky, D. J. et al. Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapidsubtraction hybridization, RaSH. Oncogene 21, 3592-3602 (2002). (Pubitemid 34587691)
33. Warr, T., Ward, S., Burrows, J., Harding, B., Wilkins, P., Harkness, W. et al. Identification of extensive genomic loss and gain by comparative genomic hybridisation in malignant astrocytoma in children and young adults. Genes Chromosomes Cancer 31, 15-22 (2001). (Pubitemid 32274128)
34. Lee, S. G., Jeon, H. Y., Su, Z. Z., Richards, J. E., Vozhilla, N., Sarkar, D. et al. Astrocyte elevated gene-1 contributes to the pathogenesis of neuroblastoma. Oncogene 28, 2476-2484 (2009).
35. Yu, C., Chen, K., Zheng, H., Guo, X., Jia, W., Li, M. et al. Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis. Carcinogenesis 30, 894-901 (2009).
36. Hu, G., Chong, R. A., Yang, Q., Wei, Y., Blanco, M. A., Li, F. et al. MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. Cancer Cell 15, 9-20 (2009).
37. Kikuno, N., Shiina, H., Urakami, S., Kawamoto, K., Hirata, H., Tanaka, Y. et al. Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity. Oncogene 26, 7647-7655 (2007). (Pubitemid 350224215)
38. Yoo, B. K., Emdad, L., Su, Z. Z., Villanueva, A., Chiang, D. Y., Mukhopadhyay, N. D. et al. Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J. Clin. Invest. 119, 465-477 (2009).
39. Lee, S. G., Su, Z. Z., Emdad, L., Sarkar, D., Franke, T. F. & Fisher, P. B. Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling. Oncogene 27, 1114-1121 (2008). (Pubitemid 351253177)
40. Sarkar, D., Park, E. S., Emdad, L., Lee, S. G., Su, Z. Z. & Fisher, P. B. Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1. Cancer Res. 68, 1478-1484 (2008). (Pubitemid 351346856)